Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4977 USD | +15.21% | +8.20% | -29.00% |
05-10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
610M | - | - | - | - | - | |
122B | ||||||
113B | ||||||
22.66B | - | |||||
16.68B | - | |||||
16.61B |